赛诺菲终止一项大肠杆菌疫苗试验 损失约2.5亿美元

智通财经APP
13 Feb

法国医药巨头赛诺菲与美国同行强生公司结束了对一款试验性疫苗的开发工作,因为该疫苗未能有效防止一种侵袭性的消化道病原大肠杆菌。赛诺菲在一份声明中表示,由于这一最新的决定,公司在2024年第四季度的财报中记录了大约2.5亿美元的减值损失。但是赛诺菲表示这一决定不会对赛诺菲当前财年的财务预期产生任何影响。这一举动对全球医学界预防大肠杆菌败血症的努力是一次打击,因为目前尚无有效的实质预防措施。赛诺菲与强生...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10